If the oxygen tension in the tumor microenvironment can modulate the estrogen effects on GPER and VEGF this could provide a mechanism for opposing effects of estrogen depending on the CRC stage and the site of sampling from tumor biopsies. The gene discussed is GPER1; the disease is colorectal carcinoma.